Cargando…
Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial
Autores principales: | Van Eijk, MM, Roes, KC, Honing, ML, Kuiper, MA, Karakus, A, Van der JAgt, M, Spronk, PE, Van Gool, WA, Van der Mast, RC, Kesecioglu, J, Slooter, AJ |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3067013/ http://dx.doi.org/10.1186/cc9759 |
Ejemplares similares
-
Haloperidol, clonidine and resolution of delirium in critically ill patients: a prospective cohort study
por: Smit, Lisa, et al.
Publicado: (2021) -
Prevention of ICU delirium and delirium-related outcome with haloperidol: a study protocol for a multicenter randomized controlled trial
por: van den Boogaard, Mark, et al.
Publicado: (2013) -
Pharmacokinetics of Haloperidol in Critically Ill Patients: Is There an Association with Inflammation?
por: Li, Letao, et al.
Publicado: (2022) -
Drug Persistency Patterns for Patients Treated With Rivastigmine or Donepezil in Usual Care Settings
por: Mauskopf, Josephine A., et al.
Publicado: (2005) -
Delirium assessment in daily critical care with the CAM-ICU: a multicenter study
por: Van Eijk, MM, et al.
Publicado: (2011)